Novavax reports strong immune responses from H5N1 avian flu vaccine candidate, showing promise in single and two-dose ...

Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

Nuvaxovid was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) yesterday, becoming the fifth COVID-19 vaccine to be authorised in the UK.

Find the latest Novavax, Inc. (NVAX) stock quote, history, news and other vital information to help you with your stock trading and investing.

The tightened approach ties in with the FDA's recent approval of Novavax's recently approved Nuvaxovid shot, which has only been cleared for this older, more vulnerable age group rather than for ...